Clinicopathologic significance of expression of nuclear factor-&kappa;B RelA and its target gene products in gastric cancer patients

doi:10.3748/wjg.v18.i34.4744

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 34

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3178)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

301

HTML

2624

Figures (1-2)

127

Tables (1-4)

126

Sum=3178

Sep 14, 2012 (publication date) through May 7, 2024

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 14, 2012; 18(34): 4744-4750
Published online Sep 14, 2012. doi: 10.3748/wjg.v18.i34.4744

Open in New Tab Full Size Figure Download Figure

Figure 1 Immunohistochemical staining for nuclear factor-κB RelA in gastric cancer. Gastric cancer cells evidence intense cytoplasmic immunoreactivity for nuclear factor-κB (× 200; inset, × 40).

Open in New Tab Full Size Figure Download Figure

Figure 2 Overall survival curve. A: Serum amyloid A (SAA) expression (P < 0.001); B: Nuclear factor-κB (NF-κB) expression (P < 0.001).

Citation: Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Jang JS, Kim MC, Kim KH, Kim SJ, Kim SG, Kim HJ. Clinicopathologic significance of expression of nuclear factor-κB RelA and its target gene products in gastric cancer patients. World J Gastroenterol 2012; 18(34): 4744-4750
URL: https://www.wjgnet.com/1007-9327/full/v18/i34/4744.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i34.4744